Cited by 364Cannabis and Cannabinoid ResearchMedicinal Plant Extracts EffectsAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Effects of ipsapirone and cannabidiol on human experimental anxiety

Zuardi, A. W., Cosme, R. A., Graeff, F. G., Guimarães, F. S.·1993·Journal of Psychopharmacology

DOI 10.1177/026988119300700112

Open this paper in CoChat — free account

Abstract

The effects of ipsapirone and cannabidiol (CBD) on healthy volunteers submitted to a simulated public speaking (SPS) test were compared with those of the anxiolytic benzodiazepine diazepam and placebo. Four independent groups of 10 subjects received, under a double-blind design, placebo or one of the following drugs: CBD (300 mg), diazepam (10 mg) or ipsapirone (5 mg). Subjective anxiety was evaluated through the Visual Analogue Mood Scale (VAMS) and the State-trait Anxiety Inventory (STAI). The VAMS anxiety factor showed that ipsapirone attenuated SPS-induced anxiety while CBD decreased anxiety after the SPS test. Diazepam, on the other hand, was anxiolytic before and after the SPS test, but had no effect on the increase in anxiety induced by the speech test. Only ipsapirone attenuated the increase in systolic blood pressure induced by the test. Significant sedative effects were only observed with diazepam. The results suggest that ipsapirone and CBD have anxiolytic properties in human volunteers submitted to a stressful situation.

Integrity signals

Registry

Crossref · 10.1177/026988119300700112

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Untitled work
(1970) · Cited by 24,983
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Manual for the Wechsler Adult Intelligence Scale.
Wechsler, D. (1955) · Psychological Corp. eBooks · Cited by 4,941
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
The use of analogue scales in rating subjective feelings
BOND, A., & LADER, M. (1974) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1974.tb02285.x · Cited by 1,972
The development of a scale to measure fear
Geer, J. H. (1965) · Behaviour Research and Therapy · doi:10.1016/0005-7967(65)90040-9 · Cited by 777
Action of cannabidiol on the anxiety and other effects produced by ?9-THC in normal subjects
Zuardi, A. W., Shirakawa, I., Finkelfarb, E., & Karniol, I. G. (1982) · Psychopharmacology · doi:10.1007/bf00432554 · Cited by 608
Chronic Administration of Cannabidiol to Healthy Volunteers and Epileptic Patients
Cunha, J. M., Carlini, E. A., Pereira, A. E., Ramos, O. L., Pimentel, C., Gagliardi, R. J., Sanvito, W. L., Lander, N., & Mechoulam, R. (2008) · Pharmacology · doi:10.1159/000137430 · Cited by 570
Pharmacology of Marihuana
Pertwee, R. G. (1977) · Neuroscience · doi:10.1016/0306-4522(77)90080-x · Cited by 384
The action of sedatives on brain stem oculomotor systems in man
Norris, H. (1971) · Neuropharmacology · doi:10.1016/0028-3908(71)90039-6 · Cited by 384

Show all 39 references

Research works printed but not linked: 10

Biaggio A M B, 1976, Cross-cultural research on anxiety., 29
Critchley M A E, 1987, Br J Pharmacol, 92, 660
Geer J H, 1965, Behav Res Ther, 193, 785
Gregg J M, 1976, J Oral Surg, 34, 301
Guimarães F S, 1989, Brazilian J Med Biol Res, 22, 1083
Higgins G A, 1987, Br J Pharmacol, 92, 658P
Kuemmel B, 1988, Psychopharmacology, 96, 353, 10.1007/BF00216061 · DOI
Norusis M J, 1988, SPSS/PC + advanced stataistics V. 2.0
Zuardi A W, 1981, J Brasileiro Psiquiatr, 131, 403
Zuardi A W, 1983, Ar Biol Technol, 26, 391

Sorted by citations

Items 101–200 of 362

Evaluating cannabidiol (CBD) expectancy effects on acute stress and anxiety in healthy adults: a randomized crossover study
Spinella, T. C., Stewart, S. H., Naugler, J., Yakovenko, I., & Barrett, S. P. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05823-w · Cited by 69
Handbook of Psychotropic Herbs: A Scientific Analysis of Herbal Remedies for Psychiatric Conditions
Ross, E. M. (2001) · Nutrition in Clinical Care · doi:10.1046/j.1523-5408.2001.00147.x · Cited by 70
Cannabis use and sleep: Expectations, outcomes, and the role of age
Winiger, E. A., Hitchcock, L. N., Bryan, A. D., & Bidwell, L. C. (2020) · Addictive Behaviors · doi:10.1016/j.addbeh.2020.106642 · Cited by 72
Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: Contribution of 5HT1A receptors and stressful experiences
Marinho, A. L. Z., Vila-Verde, C., Fogaça, M. V., & Guimarães, F. S. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.02.023 · Cited by 68
Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review
Hasbi, A., Madras, B. K., & George, S. R. (2023) · Brain Sciences · doi:10.3390/brainsci13020325 · Cited by 69
Pharmacological challenge studies with acute psychosocial stress
Hedger, K. V., Bershad, A. K., & de Wit, H. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.08.020 · Cited by 70
Cannabidiolic acid methyl ester, a stable synthetic analogue of cannabidiolic acid, can produce 5‐HT1A receptor‐mediated suppression of nausea and anxiety in rats
Pertwee, R. G., Rock, E. M., Guenther, K. G., Limebeer, C. L., Stevenson, L., Haj, C. G., Smoum, R., Parker, L. A., & Mechoulam, R. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14073 · Cited by 66
Cannabidiol attenuates aggressive behavior induced by social isolation in mice: Involvement of 5-HT1A and CB1 receptors
dos Santos, A. H., Lisboa, S. F. D. S., Sonego, A. B., Coutinho, D., Gomes, F. V., & Guimarães, F. S. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109637 · Cited by 71
Is cannabidiol the ideal drug to treat non-motor Parkinson’s disease symptoms?
Crippa, J. A. S., Hallak, J. E. C., Zuardi, A. W., Guimarães, F. S., Tumas, V., & SANTOS, R. G. D. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-00982-6 · Cited by 66
Targeting the endocannabinoid system to treat anxiety-related disorders
Korem, N., Zer‐Aviv, T. M., Ganon-Elazar, E., Abush, H., & Akirav, I. (2015) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2015-0058 · Cited by 69
Improved Bioavailability with Dry Powder Cannabidiol Inhalation: A Phase 1 Clinical Study
Devinsky, O., Kraft, K. S., Rusch, L. M., Fein, M., & Leone‐Bay, A. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.08.012 · Cited by 64
Religion, synchrony, and cooperation
Cohen, E. E. A., Mundry, R., & Kirschner, S. (2013) · Religion Brain & Behavior · doi:10.1080/2153599x.2012.741075 · Cited by 61
Antiaversive Effects of Cannabinoids: Is the Periaqueductal Gray Involved?
Moreira, F. A., de Aguiar, D. C., Campos, A. C., Lisboa, S. F. D. S., Terzian, A. L. B., Resstel, L. B. M., & Guimarães, F. S. (2008) · Neural Plasticity · doi:10.1155/2009/625469 · Cited by 62
The Cannabinoids: An Overview. Therapeutic Implications in Vomiting and Nausea after Cancer Chemotherapy, in Appetite Promotion, in Multiple Sclerosis and in Neuroprotection
Mechoulam, R., & Hanus, L. O. (2001) · Pain Research and Management · doi:10.1155/2001/183057 · Cited by 60
Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions
Henson, J. D., Vitetta, L., & Hall, S. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01020-z · Cited by 62
Cannabidiol and brain function: current knowledge and future perspectives
Schouten, M., Dalle, S., Mantini, D., & Koppo, K. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1328885 · Cited by 64
Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study
de Meneses-Gaya, C., Crippa, J. A. S., Hallak, J. E. C., Miguel, A. C., Laranjeira, R., Bressan, R. A., Zuardi, A. W., & Lacerda, A. L. T. (2020) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2020-1416 · Cited by 59
Subjective and neurovegetative changes in healthy volunteers and panic patients performing simulated public speaking
Parente, A. C. B. V., Garcia-Leal, C., Del‐Ben, C. M., Guimarães, F. S., & Graeff, F. G. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.05.002 · Cited by 59
The effects of cannabidiol on male reproductive system: A literature review
de Carvalho, R. K., Andersen, M. L., & Mazaro‐Costa, R. (2019) · Journal of Applied Toxicology · doi:10.1002/jat.3831 · Cited by 58
Evaluation of Patient Reported Safety and Efficacy of Cannabis From a Survey of Medical Cannabis Patients in Canada
Cahill, S. P., Lunn, S. E., Diaz, P. L., & Page, J. E. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.626853 · Cited by 56
Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind, and placebo-controlled clinical trial
Júnior, E. A. D. S., Medeiros, W. M. B., dos Santos, J. P. M., de Sousa, J. M. M., da Costa, F. B., Pontes, K. M., Borges, T. C., Segundo, C. E. N., Silva, A. H. A. E., Nunes, E. L. G., et al. (2022) · Trends in Psychiatry and Psychotherapy · doi:10.47626/2237-6089-2021-0396 · Cited by 91
The therapeutic potential of purified cannabidiol
O’Sullivan, S. E., Jensen, S. S., Nikolajsen, G. N., Bruun, H. Z., Bhuller, R., & Hoeng, J. (2023) · Journal of Cannabis Research · doi:10.1186/s42238-023-00186-9 · Cited by 61
The role of serotonin in depression and anxiety
Deakin, J. F. W. (1998) · European Psychiatry · doi:10.1016/s0924-9338(98)80015-1 · Cited by 56
The Endocannabinoid System and Anxiety
Lisboa, S. F. D. S., Gomes, F. V., Terzian, A. L. B., de Aguiar, D. C., Moreira, F. A., Resstel, L. B. M., & Guimarães, F. S. (2016) · Vitamins and hormones · doi:10.1016/bs.vh.2016.09.006 · Cited by 56
Use of the elevated T-maze to study anxiety in mice
de Carvalho-Netto, E. F., & Nunes‐de‐Souza, R. L. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00184-0 · Cited by 55
Cannabidiol Does Not Dampen Responses to Emotional Stimuli in Healthy Adults
Arndt, D. L., & de Wit, H. (2017) · Cannabis and Cannabinoid Research · doi:10.1089/can.2017.0014 · Cited by 55
The Pharmacological History of Cannabis
Russo, E. B. (2014) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199662685.003.0002 · Cited by 53
Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance
Jîtcă, G., Ősz, B. E., Vari, C.-E., Rusz, C.-M., Tero-Vescan, A., & Puşcaş, A. (2023) · Antioxidants · doi:10.3390/antiox12020485 · Cited by 58
The Impact of Cannabidiol on Psychiatric and Medical Conditions
Oberbarnscheidt, T., & Miller, N. S. (2020) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4159 · Cited by 55
Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot
Pennypacker, S. D., Cunnane, K., Cash, M. C., & Romero-Sandoval, E. A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.921493 · Cited by 58
Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19
Malinowska, B., Baranowska‐Kuczko, M., Kicman, A., & Schlicker, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041986 · Cited by 50
Cannabis craving in response to laboratory-induced social stress among racially diverse cannabis users: The impact of social anxiety disorder
Buckner, J. D., Zvolensky, M. J., Ecker, A. H., & Jeffries, E. R. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116629115 · Cited by 52
Examination of a New Delivery Approach for Oral Cannabidiol in Healthy Subjects: A Randomized, Double-Blinded, Placebo-Controlled Pharmacokinetics Study
Patrician, A., Bratinčević, M. V., Mijačika, T., Banić, I., Marendić, M., Sutlović, D., Dujić, Ž., & Ainslie, P. N. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01074-6 · Cited by 51
CBD and THC: Do They Complement Each Other Like Yin and Yang?
Pennypacker, S. D., & Romero-Sandoval, E. A. (2020) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2469 · Cited by 54
Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: A randomised controlled trial
Kwee, C., Baas, J. M. P., van der Flier, F. E., Groenink, L., Duits, P., Eikelenboom, M., van der Veen, D. C., Moerbeek, M., Batelaan, N. M., van Balkom, A. J. L. M., et al. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.04.003 · Cited by 50
Cannabis in Veterinary Medicine: Cannabinoid Therapies for Animals
Hartsel, J. A., Boyar, K., Pham, A., Silver, R. J., & Makriyannis, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-04624-8_10 · Cited by 56
Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial
McCartney, D., Suraev, A. S., Doohan, P. T., Irwin, C. G., Kevin, R. C., Grunstein, R. R., Hoyos, C. M., & McGregor, I. S. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221095356 · Cited by 51
A comparison of cannabidiolic acid with other treatments for anticipatory nausea using a rat model of contextually elicited conditioned gaping
Rock, E. M., Limebeer, C. L., Navaratnam, R., Sticht, M. A., Bonner, N., Engeland, K., Downey, R. I., Morris, H. I., Jackson, M., & Parker, L. A. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3498-1 · Cited by 48
Evidences for the Anti-panic Actions of Cannabidiol
Soares-Rachetti, V. D. P., & Campos, A. C. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160509123955 · Cited by 52
Cannabidiol for the treatment of autism spectrum disorder: hope or hype?
Pedrazzi, J. F. C., Ferreira, F. R., Silva-Amaral, D., Lima, D. D. A., Hallak, J. E. C., Zuardi, A. W., Bel, E. A. D., Guimarães, F. S., Costa, K. C. M., Campos, A. C., et al. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06196-4 · Cited by 53
The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis
Hahn, B. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx105 · Cited by 52
Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial
Dahlgren, M. K., Lambros, A. M., Smith, R. T., Sagar, K. A., El-Abboud, C., & Gruber, S. A. (2022) · Communications Medicine · doi:10.1038/s43856-022-00202-8 · Cited by 54
Cannabinoid Modulation of Fear Extinction Brain Circuits: A Novel Target to Advance Anxiety Treatment
Rabinak, C. A., & Phan, K. L. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990437 · Cited by 49
Cannabidiol inhibits sucrose self‐administration by CB 1 and CB 2 receptor mechanisms in rodents
Bi, G., Galaj, E., He, Y., & Xi, Z. (2019) · Addiction Biology · doi:10.1111/adb.12783 · Cited by 48
Cannabidiol for the Treatment of Brain Disorders: Therapeutic Potential and Routes of Administration
Yau, G. T. Y., Tai, W., Arnold, J. C., Chan, H., & Kwok, P. C. L. (2023) · Pharmaceutical Research · doi:10.1007/s11095-023-03469-1 · Cited by 48
Is there a role for cannabidiol in psychiatry?
Khoury, J. M., das Neves, M. D. C. L., Roque, M. A. V., Queiroz, D. A. D. B., de Freitas, A. A. C., de Fátima, Â., Moreira, F. A., & Garcia, F. D. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1285049 · Cited by 45
Treating Pediatric Anxiety
Bushnell, G., Compton, S. N., Dusetzina, S. B., Gaynes, B. N., Brookhart, M. A., Walkup, J. T., Rynn, M. A., & Stürmer‎, T. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16m11415 · Cited by 45
Effect of d -fenfluramine on human experimental anxiety
Hetem, L. A. B., de Souza, C. J., Guimarães, F. S., Zuardi, A. W., & Graeff, F. G. (1996) · Psychopharmacology · doi:10.1007/s002130050086 · Cited by 45
Do panic patients process unconditioned fear vs. conditioned anxiety differently than normal subjects?
Del‐Ben, C. M., Vilela, J. A. A., Hetem, L. A. B., Guimarães, F. S., Graeff, F. G., & Zuardi, A. W. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(01)00312-2 · Cited by 43
New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders
Scherma, M., Masia, P., Deidda, M. L., Fratta, W., Tanda, G., & Fadda, P. (2018) · Medicines · doi:10.3390/medicines5040107 · Cited by 43
Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers
Woelfl, T., Rohleder, C., Mueller, J. K., Lange, B., Reuter, A. R., Schmidt, A. M., Koethe, D., Hellmich, M., & Leweke, F. M. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.576877 · Cited by 41
Glial Cells and Their Contribution to the Mechanisms of Action of Cannabidiol in Neuropsychiatric Disorders
Scarante, F. F., Ribeiro, M. A., Almeida-Santos, A. F., Guimarães, F. S., & Campos, A. C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.618065 · Cited by 44
Oxytocin interference in the effects induced by inhalation of 7.5% CO2 in healthy volunteers
de Oliveira, D. C. G., Chagas, M. H. N., Garcia, L. V., Crippa, J. A. S., & Zuardi, A. W. (2012) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2237 · Cited by 39
Effects of ∆9-tetrahydrocannabinol on aversive memories and anxiety: a review from human studies
Raymundi, A. M., da Silva, T. R., Sohn, J. M. B., Bertoglio, L. J., & Stern, C. A. J. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02813-8 · Cited by 43
Palmitoylethanolamide: A Potential Alternative to Cannabidiol
Clayton, P., Subah, S., Venkatesh, R., Hill, M., & Bogoda, N. O. (2021) · Journal of Dietary Supplements · doi:10.1080/19390211.2021.2005733 · Cited by 42
A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis
Davies, C., Wilson, R. P., Appiah‐Kusi, E., Blest‐Hopley, G., Brammer, M. J., Pérez, J., Murray, R. M., Allen, P., Bossong, M. G., McGuire, P. K., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0862-2 · Cited by 40
An Observational, Longitudinal Study of Cognition in Medical Cannabis Patients over the Course of 12 Months of Treatment: Preliminary Results
Sagar, K. A., Dahlgren, M. K., Lambros, A. M., Smith, R. T., El-Abboud, C., & Gruber, S. A. (2021) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617721000114 · Cited by 40
Escala para auto-avaliação ao falar em público (SSPS): adaptação transcultural e consistência interna da versão brasileira
Osório, F. D. L., Crippa, J. A. S., & Loureiro, S. R. (2008) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832008000600001 · Cited by 38
Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis
Hutten, N. R. P. W., Arkell, T. R., Vinckenbosch, F. R. J., Schepers, J., Kevin, R. C., Theunissen, E. L., Kuypers, K. P. C., McGregor, I. S., & Ramaekers, J. G. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06248-9 · Cited by 38
Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder
Bolsoni, L. M., Crippa, J. A. S., Hallak, J. E. C., Guimarães, F. S., & Zuardi, A. W. (2022) · Psychopharmacology · doi:10.1007/s00213-021-06043-y · Cited by 41
Cannabinoid treatments for anxiety: A systematic review and consideration of the impact of sleep disturbance
Narayan, A. J., Downey, L. A., Manning, B., & Hayley, A. C. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104941 · Cited by 36
The effects of cannabidiol on worry and anxiety among high trait worriers: a double-blind, randomized placebo controlled trial
Gournay, L. R., Ferretti, M. L., Bilsky, S. A., Vance, E., Nguyen, A., MANN, E. A., Williams, P., & Leen‐Feldner, E. W. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06437-0 · Cited by 41
Could Cannabidiol Be a Treatment for Coronavirus Disease-19-Related Anxiety Disorders?
O’Sullivan, S. E., Stevenson, C. W., & Laviolette, S. R. (2020) · Cannabis and Cannabinoid Research · doi:10.1089/can.2020.0102 · Cited by 37
The anxiolytic effect of cannabidiol depends on the nature of the trauma when patients with post-traumatic stress disorder recall their trigger event
Bolsoni, L. M., Crippa, J. A. S., Hallak, J. E. C., Guimarães, F. S., & Zuardi, A. W. (2022) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2021-2317 · Cited by 36
Two-weeks treatment with cannabidiol improves biophysical and behavioral deficits associated with experimental type-1 diabetes
Chaves, Y. C., Genaro, K., Stern, C. A. J., Guaita, G. D. O., Crippa, J. A. S., da Cunha, J. M., & Zanoveli, J. M. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135020 · Cited by 35
Therapeutic Applications of Cannabinoids in Cardiomyopathy and Heart Failure
Garza-Cervantes, J. A., Ramos-González, M. R., Lozano, O., Carlos Jerjes-Sánchez, D., & García‐Rivas, G. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/4587024 · Cited by 38
Dissociation between the panicolytic effect of cannabidiol microinjected into the substantia nigra, pars reticulata, and fear-induced antinociception elicited by bicuculline administration in deep layers of the superior colliculus: The role of CB1-cannabinoid receptor in the ventral mesencephalon
da Silva, J. A., Biagioni, A. F., Almada, R. C., Crippa, J. A. S., Hallak, J. E. C., Zuardi, A. W., & Coimbra, N. C. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.051 · Cited by 34
Cannabidiol in sport: Ergogenic or else?
Gamelin, F.-X., Cuvelier, G., Mendes, A., Aucouturier, J., Berthoin, S., Marzo, V. D., & Heyman, E. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104764 · Cited by 38
Evaluation of the potential use of cannabidiol in the treatment of cocaine use disorder: A systematic review
Rodrigues, L. A., Caroba, M. E. S., Taba, F. K., Filev, R., & Gallassi, A. D. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172982 · Cited by 31
Drug effects on responses to emotional facial expressions
Miller, M. A., Bershad, A. K., & de Wit, H. (2015) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000164 · Cited by 31
Ethopharmacological evaluation of the rat exposure test: A prey–predator interaction test
Campos, K. F. C., Amaral, V. C. S., Rico, J. L., Miguel, T. T., & Nunes‐de‐Souza, R. L. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.11.023 · Cited by 30
Subacute cannabidiol alters genome‐wide DNA methylation in adult mouse hippocampus
Flack, N., Colwell, M., Drown, C., & Faulk, C. D. (2020) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22396 · Cited by 31
Targeting the Endocannabinoid System in Psychiatric Illness
Katzman, M. A., Furtado, M., & Anand, L. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000581 · Cited by 30
CBD and the 5-HT1A receptor: A medicinal and pharmacological review
Alexander, C., Jeon, J., Nickerson, K., Hassler, S. N., & Vasefi, M. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116742 · Cited by 28
Hippocampal mammalian target of rapamycin is implicated in stress-coping behavior induced by cannabidiol in the forced swim test
Sartim, A. G., Sales, A. J., Guimarães, F. S., & Joca, S. R. L. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118784877 · Cited by 29
Potential Role of Cannabidiol on Sports Recovery: A Narrative Review
Rojas‐Valverde, D. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.722550 · Cited by 32
The Anxiolytic Effects of Cannabidiol (CBD)
Zuardi, A. W., Crippa, J. A. S., Hallak, J. E. C., Campos, A. C., & Guimarães, F. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00097-1 · Cited by 29
Cannabidiol administration into the bed nucleus of the stria terminalis alters cardiovascular responses induced by acute restraint stress through 5-HT1A receptor
Gomes, F. V., Alves, F. H. F., Guimarães, F. S., Correa, F. M. A., Resstel, L. B. M., & Crestani, C. C. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.09.007 · Cited by 27
Enhancing Endocannabinoid Control of Stress with Cannabidiol
Henson, J. D., Vitetta, L., Quezada, M., & Hall, S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245852 · Cited by 32
The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study
Bloomfield, M., Yamamori, Y., Hindocha, C., Jones, A., Yim, J. L., Walker, H. R., Statton, B. K., Wall, M. B., Lees, R., Howes, O. D., et al. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06070-3 · Cited by 30
Cannabidiol in clinical and preclinical anxiety research. A systematic review into concentration–effect relations using the IB-de-risk tool
Kwee, C., van Gerven, J., Bongaerts, F. L. P., Cath, D. C., Jacobs, G. E., Baas, J. M. P., & Groenink, L. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221124792 · Cited by 27
Escitalopram prolonged fear induced by simulated public speaking and released hypothalamic-pituitary-adrenal axis activation
Garcia-Leal, C., Del‐Ben, C. M., Leal, F. M., Graeff, F. G., & Guimarães, F. S. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108101782 · Cited by 24
Human experimental anxiety: actual public speaking induces more intense physiological responses than simulated public speaking
Zuardi, A. W., Crippa, J. A. S., Hallak, J. E. C., & Gorayeb, R. (2013) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2012-0930 · Cited by 24
Cannabidiol as a potential medicine
Pertwee, R. G. (2005) · Birkhäuser-Verlag eBooks · doi:10.1007/3-7643-7358-x_3 · Cited by 23
Reinforcing effects of diazepam under anxiogenic conditions in individuals with social anxiety.
Helmus, T. C., Tancer, M. E., & Johanson, C. (2005) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.13.4.348 · Cited by 24
Phytocannabinoids, the Endocannabinoid System and Male Reproduction
Lim, J., Squire, E., & Jung, K. (2022) · The World Journal of Men s Health · doi:10.5534/wjmh.220132 · Cited by 24
Anxiolytic effects of endocannabinoid enhancing compounds: A systematic review and meta-analysis
Kwee, C., Leen, N. A., der Kamp, R. C. V., Lissa, C. J. V., Cath, D. C., Groenink, L., & Baas, J. M. P. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.04.001 · Cited by 24
Experimental public speaking: Contributions to the understanding of the serotonergic modulation of fear
Garcia-Leal, C., Graeff, F. G., & Del‐Ben, C. M. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.09.011 · Cited by 23
Research and Clinical Practice Involving the Use of Cannabis Products, with Emphasis on Cannabidiol: A Narrative Review
Simei, J. L. Q., Souza, J. D. R., Pedrazzi, J. F. C., Guimarães, F. S., Campos, A. C., Zuardi, A. W., Hallak, J. E. C., & Crippa, J. A. S. (2024) · Pharmaceuticals · doi:10.3390/ph17121644 · Cited by 27
Cannabidiol in Foods and Food Supplements: Evaluation of Health Risks and Health Claims
Engeli, B. E., Lachenmeier, D. W., Diel, P. R., Guth, S., Villar-Fernandez, M., Roth, A., Lampen, A., Cartus, A. T., Wätjen, W., Hengstler, J. G., et al. (2025) · Nutrients · doi:10.3390/nu17030489 · Cited by 23
Cannabis and Mental Health
Kansagara, D. L., Terry, G. E., Ayers, C. K., & D'Souza, D. (2026) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2025.8215 · Cited by 23
Neuroanatomical substrates involved in cannabinoid modulation of defensive responses
Moreira, F. A., Aguiar, D., Resstel, L. B. M., Lisboa, S. F. D. S., Campos, A. C., Gomes, F. V., & Guimarães, F. S. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111400651 · Cited by 24
Why should Cannabis be Considered Doping in Sports?
Bergamaschi, M. M., & Crippa, J. A. S. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00032 · Cited by 22
The effect of cannabidiol on simulated car driving performance: A randomised, double‐blind, placebo‐controlled, crossover, dose‐ranging clinical trial protocol
McCartney, D., Benson, M. J., Suraev, A. S., Irwin, C. G., Arkell, T. R., Grunstein, R. R., Hoyos, C. M., & McGregor, I. S. (2020) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2749 · Cited by 21
Acute Effects of Cannabis on Symptoms of Obsessive-Compulsive Disorder
Mauzay, D., LaFrance, E. M., & Cuttler, C. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.124 · Cited by 21
Autism and associated disorders: cannabis as a potential therapy
Babayeva, M., Assefa, H., Basu, P., & Loewy, Z. G. (2022) · Frontiers in Bioscience-Elite · doi:10.31083/j.fbe1401001 · Cited by 27
Cannabidiol and its Potential Evidence-Based Psychiatric Benefits – A Critical Review
Dammann, I., Rohleder, C., & Leweke, F. M. (2024) · Pharmacopsychiatry · doi:10.1055/a-2228-6118 · Cited by 24
The acute effects of cannabidiol on the neural correlates of reward anticipation and feedback in healthy volunteers
Lawn, W., Hill, J., Hindocha, C., Yim, J. L., Yamamori, Y., Jones, G., Walker, H. R., Green, S. F., Wall, M. B., Howes, O. D., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120944148 · Cited by 20
How do stupendous cannabinoids modulate memory processing via affecting neurotransmitter systems?
Vaseghi, S., Nasehi, M., & Zarrindast, M. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.10.018 · Cited by 21
From an Alternative Medicine to a New Treatment for Refractory Epilepsies: Can Cannabidiol Follow the Same Path to Treat Neuropsychiatric Disorders?
de Bitencourt, R. M., Takahashi, R. N., & Carlini, E. A. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.638032 · Cited by 23

Authors: Zuardi, A. W., Cosme, R. A., Graeff, F. G., & Guimarães, F. S.
Affiliations: Universidade de São Paulo (BR)
ORCID: Zuardi, A. W.
Graeff, F. G.
Venue: Journal of Psychopharmacology
Publisher: SAGE Publications
Published: 1993-01
Volume: 7
Issue: 1_suppl
Pages: 82-88
ISSN: 0269-8811 (ISSN-L)
1461-7285
DOI: 10.1177/026988119300700112
OpenAlex: W1696206979
Cited by: 364
References: 39
Citations by year: 2026: 4 · 2025: 10 · 2024: 33 · 2023: 28 · 2022: 37 · 2021: 28 · 2020: 43 · 2019: 25 · 2018: 11 · 2017: 21 · 2016: 12 · 2015: 12 · 2014: 9 · 2013: 10 · 2012: 17
FWCI: 2.33
Type: journal article
Language: en
Open access: closed
Licence: journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations: Journal of Psychopharmacology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plant Extracts Effects
Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords: ipsapirone, cannabidiol, diazepam, anxiety, anxiolytic effects, stress response, blood pressure, sedation, healthy volunteers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effects of ipsapirone and cannabidiol on human experimental anxiety

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks